市场调查报告书
商品编码
1434344
自体输血系统市场:按类型、应用和最终用户划分 - 全球预测 2023-2030Autotransfusion System Market by Type (Autotransfusion Accessories, Autotransfusion Products), Application (Cardiac Surgeries, Organ Transplantation, Orthopedic Surgeries), End User - Global Forecast 2023-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2022年自体输血系统市场规模为4.9315亿美元,2023年将达5.3252亿美元,2030年将达9.2365亿美元,复合年增长率为8.15%。
自体输血系统的全球市场
主要市场统计 | |
---|---|
基准年[2022] | 4.9315亿美元 |
预测年份 [2023] | 53252万美元 |
预测年份 [2030] | 9.2365亿美元 |
复合年增长率(%) | 8.15% |
自体输血系统是医疗设备。这个过程收集手术或创伤期间流失的血液,清洗、过滤,然后将干净的血液送回给患者。使用患者自己的血液大大降低了输血相关併发症的风险,例如过敏反应和感染疾病传播。自体输血系统的采用越来越多,以减轻血库资源的压力,特别是在血液短缺或相容血型供应短缺的情况下。此外,自体输血可以减少对捐血製品的需求,从而更具成本效益,因为捐献血液製品需要严格的测试和储存程序。随着心血管外科、整形外科、妇科和创伤外科等外科手术的增加,自体输血系统已成为手术室的多功能工具。然而,自体输血系统的全球普及受到严格的监管核准和能够操作自体输血系统的熟练专业人员数量有限的限制。然而,自体输血系统的技术进步提高了效率和安全性,以及对医疗基础设施的持续投资,导致自体输血系统的采用越来越多。
区域洞察
由于需要输血的外科手术数量较多、对技术先进系统的强烈偏好以及对创新和研发的投资,自体输血系统市场在美洲高度发达。由于当地医疗保健系统优先考虑患者安全和成本效率,因此对自体输血系统的需求稳定,特别是在公共领域。欧盟 (EU) 自体输血系统市场是由成熟的医疗保健产业和不断增加的外科手术数量所推动的。消费者重视安全性和有效性,偏好符合欧盟医疗设备法规的设备。由于医疗游客数量的增加和医疗基础设施的发展,中东和非洲对自体输血系统的兴趣正在增加。亚太地区快速成长的医疗保健产业正在激发人们对自体输血系统的浓厚兴趣,政府透过投资支持研究和创新。对负担得起的医疗设备的强烈兴趣和持续的健康倡议推动了国内生产和研究,以减少进口,并使亚太地区的医疗保健提供者更容易获得自体输血系统。
FPNV定位矩阵
FPNV定位矩阵对于评估自体输血系统市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对自体输血系统市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1-市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2-市场开拓:我们深入研究利润丰厚的新兴市场,并分析它们在成熟细分市场中的渗透率。
3- 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4-竞争力评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5- 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1-自体输血系统市场的市场规模与预测是多少?
2-自体输血系统市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些?
3-自体输血系统市场的技术趋势和法律规范是什么?
4-自体输血系统市场主要供应商的市场占有率是多少?
5-进入自体输血系统市场合适的型态和策略手段是什么?
[193 Pages Report] The Autotransfusion System Market size was estimated at USD 493.15 million in 2022 and expected to reach USD 532.52 million in 2023, at a CAGR 8.15% to reach USD 923.65 million by 2030.
Global Autotransfusion System Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2022] | USD 493.15 million |
Estimated Year [2023] | USD 532.52 million |
Forecast Year [2030] | USD 923.65 million |
CAGR (%) | 8.15% |
Autotransfusion systems are medical devices designed for collecting, processing, and reinfusion of the patient's own blood. This process entails collecting blood that has been lost during surgery or trauma, washing and filtering it, and then returning the cleaned blood to the patient. By using the patient's own blood, the risk of transfusion-related complications, such as allergic reactions or transmission of infectious diseases, is significantly reduced. The adoption of autotransfusion systems is increasing to mitigate the pressure on blood bank resources, particularly in times of scarcity or when matching blood types are in short supply. In addition, autotransfusion may be more cost-effective by decreasing the need for donated blood products, which require rigorous testing and storage procedures. The rise in surgical procedures, including cardiovascular, orthopedic, gynecological, and trauma surgeries, makes autotransfusion systems a versatile tool in the operating room. However, stringent regulatory approvals and limited availability of skilled professionals to operate autotransfusion systems limit the product penetration worldwide. Nevertheless, technological advancements in autotransfusion systems that improve efficiency and safety with ongoing investments in healthcare infrastructure are increasing the adoption of autotransfusion systems.
Regional Insights
The Americas represents a highly developing autotransfusion systems market due to the high volume of surgical procedures that require blood transfusions, a strong preference for technologically advanced systems, and investments in innovation and research within the sector. The regional healthcare system prioritizes patient safety and cost-efficiency, leading to a steady need for autotransfusion systems, particularly within the public health sector. In the European Union, the autotransfusion systems market is driven by a well-established healthcare sector and an increasing number of surgeries. Consumers prefer devices that align with EU medical device regulations, emphasizing safety and efficacy. The growing interest in the autotransfusion system in the Middle East and Africa is due to the increasing number of medical tourists and the development of healthcare infrastructure. Asia-Pacific's rapidly growing healthcare sector has prompted significant interest in autotransfusion systems, with the government supporting research and innovation through investments. A keen interest in affordable medical devices and ongoing health initiatives encourage domestic production and research to reduce imports and make autotransfusion systems more accessible to healthcare providers across the Asia-Pacific region.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Autotransfusion System Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Autotransfusion System Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Autotransfusion System Market, highlighting leading vendors and their innovative profiles. These include B. Braun SE, Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd., Braile Biomedica, Carolina Autotransfusion, Inc., Fresenius Medical Care AG & Co. KGaA, Gen World Medical Devices, Getinge AB, Global Blood Resources, LLC, Grifols, S.A., Haemonetics Corporation, i-SEP, Keystone Perfusion, Livanova PLC, Medtronic PLC, ProCell Surgical Inc., Redax S.p.A., Sarstedt AG & Co. KG, Sisu Global Health, SpecialtyCare, Teleflex Incorporated, Terumo Corporation, and Zimmer Biomet Holdings, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Autotransfusion System Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Autotransfusion System Market?
3. What are the technology trends and regulatory frameworks in the Autotransfusion System Market?
4. What is the market share of the leading vendors in the Autotransfusion System Market?
5. Which modes and strategic moves are suitable for entering the Autotransfusion System Market?